Association of interleukin-23 receptor variants with ankylosing spondylitis

Arthritis and Rheumatism

Volumn 58, Issue 4, 2008, Pages 1020-1025

  Rahman, Proton ^a   Inman, Robert D ^b   Gladman, Dafna D ^b   Reeve, Jeff P ^c   Peddle, Lynette ^a   Maksymowych, Walter P ^c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CANADA; CAUCASIAN; CHROMOSOME 1P; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENTERITIS; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATIENT SATISFACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PSORIASIS; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLARTHRITIS; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADULT; CANADA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RECEPTORS, INTERLEUKIN; SPONDYLITIS, ANKYLOSING;

EID: 42449146934     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23389     Document Type: Article

References (24)

1. Reveille JD. The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 2006;18:332-41.
2. Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 2004;50:2246-54.
3. Timms AE, Crane AM, Sims AM, Cordell HJ, Bradbury LA, Abbott A, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004;75:587-95.
4. Maksymowych WP, Reeve JP, Reveille JD, Akey JM, Buenviaje H, O'Brien L, et al. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Arthritis Rheum 2003;48:2011-8.
5. Carter KW, Pluzhnikov A, Timms AE, Miceli-Richard C, Bourgain C, Wordsworth BP, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology (Oxford) 2007; 46:763-71.
6. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-3.
7. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007;80:273-90.
8. Veal CD, Clough RL, Barber RC, Mason S, Tillman D, Ferry B, et al. Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet 2001;38:7-13.
9. Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, et al. Inflammatory eye, skin, and bowel disease in spondylarthritis: genetic, phenotypic, and environmental factors. J Rheumatol 2001;28:2667-73.
10. Thjodleifsson B, Geirsson AJ, Bjornsson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum 2007;56:2633-9.
11. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
12. Purcell S, Sham P. WHAP: SNP haplotype analysis package. URL: http://pngu.mgh.harvard.edu/~purcell/whap/.
13. Clayton D. SNPHAP: a program for estimating frequencies of large haplotypes of SNPs. URL: http://www-gene.cimr.cam.ac.uk/clayton/software/.
14. Neurath MF. IL-23: a master regulator in Crohn disease. Nat Med 2007:13:26-8.
15. Matsui M. Roles of the novel interleukin-12-associated cytokine, interleukin-23, in the regulation of T-cell-mediated immunity. Hepatol Res 2007;37 Suppl 3:S310-8.
16. Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002;110:493-7.
17. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910-4.
18. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005;5:521-31.
19. Im W, Kim H, Yun D, Seo SY, Park SH, Locksley RM, et al. Cytokine reporter mouse system for screening novel IL12/23 p40-inducing compounds. Mol Cells 2005;20:288-96.
20. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51.
21. Reveille JD, Zhou X, Bradbury LA, Cardon LR, Davis JC, Deloukas P, et al. IL-23R is a major determinant of ankylosing spondylitis risk - the TASC study. Ann Rheum Disease 2007;66 Suppl II:S112.
22. Lin P, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007;80:531-8.
23. Rahman P, Jones A, Curtis J, Bartlett S, Peddle L, Fernandez BA, et al. The Newfoundland population: a unique resource for genetic investigation of complex diseases [published erratum appears in Hum MoI Genet 2004;13:1287]. Hum Mol Genet 2003;12 Spec No 2:R167-72.
24. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, et al, for the CNTO 1275 Psoriasis Study Group. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007;356:580-92.